Drupal.behaviors.print = function(context) {window.print();window.close();}>

Merck, LabCorp in PGx Licensing Deal

July 28, 2010

Merck, LabCorp in PGx Licensing Deal

Merck granted LabCorp a non-exclusive license covering a polymorphism associated with a successful response to peginterferon alpha-based therapy.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories